Try our Advanced Search for more refined results

Deals Rumor Mill: Teva, Mylan, Philip Morris, China Network

By Linda Chiem (July 6, 2015, 6:18 PM EDT) -- Teva Pharmaceutical Industries Ltd. continues its aggressive courtship of rival drugmaker Mylan NV by preparing to raise its takeover bid for Mylan by as much as $2 billion, to $43 billion, Bloomberg reported Monday. Teva is apparently getting ready to make an improved offer of $86 to $88 a share for Mylan, which would top the $82-per-share offer that Teva made in April and set off a war of words between the two generic drugmakers as Mylan spurned Teva's advances. Mylan rejected Teva's $40.1 billion takeover offer, saying it would rather continuing pursuing its own $35.6 billion offer for the Irish drug company Perrigo PLC. Perrigo itself has shunned Mylan's offer....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!